Table 1. Characteristics of the patient cohort for this study.
Sydney cohort | Excluded | Included | Included relapse | |||||
n = 342 | n = 89 | n = 253 | n = 53 | |||||
Standard risk (n) | 70 | 20% | 16 | 18% | 54 | 21% | 4 | 8% |
Medium risk (n) | 231 | 68% | 68 | 76% | 163 | 64% | 37 | 70% |
High risk (n) | 41 | 12% | 5 | 6% | 36 | 14% | 12 | 23% |
Males (n) | 200 | 58% | 51 | 57% | 149 | 59% | 37 | 70% |
Females (n) | 142 | 42% | 38 | 43% | 104 | 41% | 16 | 30% |
T-ALL (n) | 40 | 12% | 10 | 11% | 30 | 12% | 6 | 11% |
prec B-ALL(n) | 302 | 88% | 79 | 89% | 223 | 88% | 47 | 89% |
TELAML 1 | 67 | 20% | 13 | 15% | 54 | 21% | 6 | 11% |
Hyperdiploid>50 | 64 | 19% | 21 | 24% | 43 | 17% | 7 | 13% |
BCRABL 1 | 7 | 2% | 0 | 0% | 7 | 3% | 2 | 4% |
B other | 164 | 48% | 45 | 51% | 119 | 47% | 32 | 60% |
Median age (yr) | 4.8 | 1.0–17.9 | 4.0 | 1.0–17.9 | 5.0 | 1.0–17.3 | 8.2 | 1.8–17.3 |
Median WCC | 10.3 | 0.1–547 | 7.7 | 0.7–514 | 11.7 | 0.1–547 | 16.4 | 1.8–17.3 |